OncoBlog: Driving the CAR to a Cancer Cure?
Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the
Medical Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.
Dec 19, 2013